BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7680170)

  • 1. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.
    Mañez R; White LT; Kusne S; Martin M; Demetris AJ; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):908-9. PubMed ID: 7680170
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
    Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
    Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
    Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the graft as a source of donor-type microchimerism in liver transplant patients.
    Hisanaga M; Schlitt HJ; Hundrieser J; Nakajima Y; Kanehiro H; Nakano H; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1073-5. PubMed ID: 8623231
    [No Abstract]   [Full Text] [Related]  

  • 5. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of donor-recipient HLA-DR mismatches and OKT3 prophylaxis on cadaver kidney graft survival.
    Vereerstraeten P; Dupont E; Andrien M; De Pauw L; Abramowicz D; Goldman M; Kinnaert P
    Transplantation; 1995 Aug; 60(3):253-8. PubMed ID: 7645038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.
    Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K
    Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes.
    Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Magna LA; Donadi EA; Kraemer MH
    Transplant Proc; 2004 May; 36(4):953-5. PubMed ID: 15194331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
    Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
    [No Abstract]   [Full Text] [Related]  

  • 11. FK 506 used as rescue therapy for refractory liver allograft rejection.
    Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
    Chen M; Wade J; Levy GA; Greig PD
    Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
    [No Abstract]   [Full Text] [Related]  

  • 14. Severity of liver transplantation rejection is associated with recipient HLA type.
    Doran TJ; Derley L; Chapman J; McCaughan G; Painter D; Dorney S; Sheil AG
    Transplant Proc; 1992 Feb; 24(1):192-3. PubMed ID: 1539240
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and immunological aspects of liver allograft rejection.
    Schlitt HJ
    Transplant Proc; 1996 Feb; 28(1):514-6. PubMed ID: 8644333
    [No Abstract]   [Full Text] [Related]  

  • 16. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of HLA matching on graft survival in live donor kidney transplantations.
    Velidedeoğlu E; Bilgin N; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
    Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA matching in liver transplantation: a retrospective analysis.
    Gunson BK; Hathaway M; Buckels JA; Mayer AD; Elias E; McMaster P; Neuberger JM
    Transplant Proc; 1992 Dec; 24(6):2434-5. PubMed ID: 1465819
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.